Mitsugu Shimobayashi

Mitsugu Shimobayashi serves as an Assistant Professor (tenure track BOF) in the Department of Chronic Diseases and Metabolism at KU Leuven's Faculty of Medicine, where he also holds a council membership. His work centers on molecular endocrinology and metabolic regulation, with emphasis on adipose tissue function and energy homeostasis.

His primary research domains include:

• Mechanisms of de novo lipogenesis and carbohydrate metabolism via ChREBP-MLX pathways
• Transcriptional regulation in metabolic diseases
• Adipose tissue responses to incretin analogs and dietary interventions
• mTORC2 signaling in glucose homeostasis and neural regulation

Analysis of his 2022-2025 publications reveals consistent focus on evolutionarily conserved metabolic pathways, particularly MLX phosphorylation effects on lipid/glucose regulation and adipose tissue remodeling in obesity. His work bridges molecular biology, endocrinology, and translational metabolism research through extensive mouse model studies.

Dr. Shimobayashi leads multiple high-impact projects including:

• Preventing MASH/liver cancer via CK2-MLX targeting (2024-2028, Promotor)
• ChREBP-MLX complex regulation studies (2023-2027, Promotor)
• Glucose-sensing pathway elucidation (2022-2026, Promotor)

He mentors PhD candidates J. Seuntjens and C.E. Cadena del Castillo, with whom he publishes regularly as supervisor/corresponding author. His laboratory operates within the Clinical and Experimental Endocrinology unit, contributing to the Flow Cytometry core facility and collaborating on multi-institutional imaging and metabolic phenotyping initiatives.